Saturday 17 October 2026
Export COSM’s income statement to Excel — free account
Cosmos Health Inc.
COSM Healthcare Medical Distribution
Cosmos Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.3 million, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 28.8%, EPS was flat, free cash flow grew 9.39% and total debt rose 15.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.33
0.01
−2.94%
Follow COSM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.15 | 0.22 | 0.23 | 0.57 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(6.63) | (14.12) | (3.29) | (13.85) | |
P/B ratio |
0.55 | 0.76 | 0.82 | 1.47 | |
Price to Tangible BV |
0.95 | 1.43 | 1.60 | 2.40 | |
EV/Sales |
0.28 | 0.39 | 0.41 | 0.71 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.10) | (2.88) | (3.16) | (5.55) | |
EV/FCF |
(1.66) | (2.14) | (2.52) | (4.37) | |
Quick Ratio |
0.68 | 0.67 | 0.67 | 0.63 | |
Current Ratio |
1.05 | 1.08 | 1.00 | 0.99 | |
Net Debt/EBITDA |
(3.61) | (6.42) | (1.04) | (5.99) | |
Debt/Assets |
19.17% | 22.42% | 22.95% | 19.13% | |
Debt/Equity |
0.57 | 0.71 | 0.82 | 0.57 | |
Asset Turnover |
1.20 | 1.16 | 1.09 | 0.89 | |
Operating CF/Net income |
0.28 | 0.38 | 0.45 | 0.46 | |
Capex/Depreciation |
1.47 | (3.18) | (3.18) | (2.68) | |
Interest Coverage |
(2.91) | (2.68) | (11.26) | (2.09) | |
Research and Development Expense of Revenue |
0.36% | 0.00% | 2.08% | 0.11% | |
Selling, General and Administrative Expense of Revenue |
21.17% | 17.95% | 63.92% | 23.52% | |
Intangible Assets out of Total Assets |
0.14 | 0.15 | 0.14 | 0.13 | |
Share Based Compensation of Revenue |
2.94% | 2.99% | 2.95% | 3.33% | |
Graham Net Nets |
(0.36) | (0.38) | (0.57) | (0.24) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(336.84%) | (200.00%) | (122.00%) | (67.57%) | |
Free Cash Flow Yield |
(109.36%) | (83.46%) | (69.99%) | (28.69%) | |
Revenue per Share |
0.32 | 0.38 | 0.65 | 0.56 | |
Operating CF per Share |
(0.03) | (0.02) | (0.15) | (0.08) | |
Capex per Share |
0.01 | (0.02) | (0.03) | (0.03) | |
Free Cash Flow per Share |
(0.02) | (0.05) | (0.18) | (0.11) | |
Cash per Share |
0.04 | 0.05 | 0.12 | 0.15 | |
Shareholders Equity per Share |
0.35 | 0.42 | 0.61 | 0.76 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.35 | 0.42 | 0.61 | 0.76 | |
Free Cash Flow |
(1.20) | (2.18) | (5.60) | (3.47) | |
Working Capital |
1.83 | 2.81 | 0.12 | (0.43) | |
Capital Expenditures |
0.51 | (1.11) | (1.01) | (1.01) | |
Net Current Asset Value |
(4.12) | (5.65) | (8.66) | (8.25) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.03) | 0.06 | 0.05 | 0.06 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
19.07 | 18.11 | 18.39 | 19.20 | |
Average Payables |
13.96 | 13.55 | 14.53 | 13.65 | |
Average Inventory |
4.81 | 5.19 | 5.07 | 5.28 | |
Average Assets |
61.65 | 59.78 | 59.89 | 67.01 | |
Average Common Equity |
23.45 | 22.89 | 21.48 | 29.06 |
Columns are period end dates